Literature DB >> 23154274

TLRs and IFNs: critical pieces of the autoimmunity puzzle.

Argyrios N Theofilopoulos1.   

Abstract

Discoveries revealing the molecular basis of innate immune responses, particularly the identification of Toll-like receptors (TLRs) as the major recognition sensors for microbial and even self-molecules, have provided new insights into the pathogenesis of both systemic and organ-specific autoimmune diseases. These insights will permit the development of novel treatment modalities for these disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23154274      PMCID: PMC3461918          DOI: 10.1172/JCI63835

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

Review 1.  The biology and detection of immune complexes.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

Authors:  P Blanco; A K Palucka; M Gill; V Pascual; J Banchereau
Journal:  Science       Date:  2001-11-16       Impact factor: 47.728

3.  Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc.

Authors:  B R Lawson; G J Prud'homme; Y Chang; H A Gardner; J Kuan; D H Kono; A N Theofilopoulos
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

4.  Isolation of circulating immune complexes using Raji cells. Separation of antigens from immune complexes and production of antiserum.

Authors:  A N Theofilopoulos; R A Eisenberg; F J Dixon
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

5.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

6.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

7.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.

Authors:  O T Preble; R J Black; R M Friedman; J H Klippel; J Vilcek
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

8.  Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

Authors:  Marie-Laure Santiago-Raber; Roberto Baccala; Katarina M Haraldsson; Divaker Choubey; Timothy A Stewart; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

9.  Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.

Authors:  A N Theofilopoulos; C B Wilson; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

10.  Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.

Authors:  Lynda Bennett; A Karolina Palucka; Edsel Arce; Victoria Cantrell; Josef Borvak; Jacques Banchereau; Virginia Pascual
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  14 in total

1.  Suppression of systemic autoimmunity by the innate immune adaptor STING.

Authors:  Shruti Sharma; Allison M Campbell; Jennie Chan; Stefan A Schattgen; Gregory M Orlowski; Ribhu Nayar; Annie H Huyler; Kerstin Nündel; Chandra Mohan; Leslie J Berg; Mark J Shlomchik; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 2.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 3.  Autoimmunity versus autoinflammation--friend or foe?

Authors:  Nobuo Kanazawa; Georgi Tchernev; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-07-09

4.  TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice.

Authors:  Benoit Desnues; Amanda Beatriz Macedo; Annie Roussel-Queval; Johnny Bonnardel; Sandrine Henri; Olivier Demaria; Lena Alexopoulou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

5.  The effect of polyamines on the binding of anti-DNA antibodies from patients with SLE and normal human subjects.

Authors:  Xiao Wang; Nancy A Stearns; Xingfu Li; David S Pisetsky
Journal:  Clin Immunol       Date:  2014-04-13       Impact factor: 3.969

6.  Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity.

Authors:  Sabira Mohammed; Nalanda S Vineetha; Shirley James; Jayasekharan S Aparna; Manendra Babu Lankadasari; Takahiro Maeda; Abhirupa Ghosh; Sudipto Saha; Quan-Zhen Li; Sarah Spiegel; Kuzhuvelil B Harikumar
Journal:  FASEB J       Date:  2020-01-23       Impact factor: 5.191

7.  B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex.

Authors:  Caroline H Wallace; Bill X Wu; Mohammad Salem; Ephraim A Ansa-Addo; Alessandra Metelli; Shaoli Sun; Gary Gilkeson; Mark J Shlomchik; Bei Liu; Zihai Li
Journal:  JCI Insight       Date:  2018-04-05

Review 8.  Human dendritic cell subsets and function in health and disease.

Authors:  Meredith O'Keeffe; Wai Hong Mok; Kristen J Radford
Journal:  Cell Mol Life Sci       Date:  2015-08-05       Impact factor: 9.261

9.  Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon.

Authors:  Wen-Hai Shao; Daniel H Shu; Yuxuan Zhen; Brendan Hilliard; Stephen O Priest; Matteo Cesaroni; Jenny P-Y Ting; Philip L Cohen
Journal:  Arthritis Rheumatol       Date:  2016-11       Impact factor: 10.995

10.  Anti-Inflammatory Effect of Combination of Scutellariae Radix and Liriopis Tuber Water Extract.

Authors:  Mi-Hye So; You-Kyung Choi
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.